Jay Ciezki, MD

Appointed
1996

Education & Fellowships

Fellowship - Cleveland Clinic
Advanced Radiation Oncology
Cleveland, OH United States
1996

Residency - Cleveland Clinic
Radiation Oncology
Cleveland, OH
1995

Internship - Cleveland Clinic
Pre-Radiation Oncology
Cleveland, OH
1992

Medical Education - Medical College of Wisconsin
MD
Milwaukee, WI
1991

Undergraduate - Medical College of Wisconsin
Medical School Program
Milwaukee, WI
1988

Certifications

• Radiology - Radiation Oncology

Specialty Interests

Brachytherapy, Radiation Therapy, Prostate Cancer, Bladder Cancer, Testicular Cancer, Kidney Cancer, Genitourinary Cancer, Intravascular Brachy Therapy

Awards & Honors

• Fellow, American College or Radiology

Innovations & Patents

• Ciezki JP, Jung EJ, inventors. Cleveland Clinic and Navius Corporation, assignees. Intravascular radiation delivery device. U.S. patent no. 6077213; June 20, 2000.
• Ciezki JP, Jung EJ, inventors. Cleveland Clinic and Navius Corporation, assignees. Intravascular radiation delivery device. US patent no. 6033357; March 7, 2000. 
• Jung EJ, Savage J, Ciezki JP, Tuzcu EM, inventors. Cleveland Clinic and Endosonics Corporation, assignees. Swivel tip assembly and catheter using same. U.S. patent no. 6290693; issued September 18, 2001. 
• Ciezki JP, Lee EJ, Jung EJ, Tuzcu EM, Weinhous M, Savage J, inventors. Cleveland Clinic and Endosonics Corporation, assignees. Intravascular radiation delivery device. U.S. patent no. 6309339; issued October 30, 2001. 
• Ciezki JP, Hafeli U, Bleam D, inventors. Cleveland Clinic and Jomed Inc., assignees. Method and apparatus for intravascular brachytherapy treatment planning. U.S. patent no. 6494835; issued December 17, 2002. 
• Ciezki JP, Jung EJ. Cleveland Clinic. Catheter with swivel tip. U.S. patent no. 6,387,035 B1; issued May 14, 2002.  
• Ciezki JP, inventor. Cleveland Clinic. Intravascular radiation delivery device. U.S. patent no. 6626816; issued September 30, 2003. 
• Ciezki JP, Jung EJ, Lee EJ, Tuzcu EM, Savage JD, Weinhous MS, inventors. Cleveland Clinic and Volcano Therapeutics, Inc. Intravascular radiation delivery device. U.S. Patent no. 6,725,081 B2; issued April 20, 2004.

See publications for Jay Ciezki, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/26/2024, Dr. Ciezki has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.